Morgan Stanley Nexgel, Inc. Transaction History
Morgan Stanley
- $1.39 Trillion
- Q4 2024
A detailed history of Morgan Stanley transactions in Nexgel, Inc. stock. As of the latest transaction made, Morgan Stanley holds 87,804 shares of NXGL stock, worth $313,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,804
Previous 1,600
5387.75%
Holding current value
$313,460
Previous $4,000
9600.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NXGL
# of Institutions
17Shares Held
470KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny158KShares$565,2410.0% of portfolio
-
Geode Capital Management, LLC Boston, MA60.1KShares$214,7060.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50KShares$178,4100.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$127,5020.01% of portfolio
-
New Edge Advisors, LLC New Orleans, LA20.3KShares$72,4530.0% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $19.9M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...